Wednesday, October 14, 2020

Lassogen Snags $4.5M Seed Funding

San Diego-based Lassogen, a startup developing therapeutics for disease treatment, said yesterday that it has raised $4.5M in a seed funding round. The funding was led by Playground Global with participation from Better Ventures, First In Ventures, Tsingyuan Ventures, as well as others. The comapny says it has now raised $5.1M in total funding. Lassogen said it is focused on "developing lasso peptides as an entirely new therapeutic modality", saying they may be useful for treating serious human diseases such as cancer, autoimmunity, pain, and inflammation.

---